Papers by Deepak L. Bhatt
Page 7 · newest first
- Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiographyEuropean Heart Journal · 2024
- Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES studyJournal of clinical lipidology · 2024
- Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular DiseaseJAMA Cardiology · 2024
- Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-AnalysisCirculation · 2024
- Empagliflozin after Acute Myocardial InfarctionNew England Journal of Medicine · 2024
- Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial InfarctionNew England Journal of Medicine · 2024
- Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI TrialCirculation · 2024
- Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial InfarctionJournal of the American College of Cardiology · 2024
- Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MIJournal of the American College of Cardiology · 2024
- Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety studyRMD Open · 2024
- Time to Clinical Benefit with Sotagliflozin in Patients with Type 2 Diabetes and Chronic Kidney Disease: Insights from the SCORED Randomized TrialEuropean Journal of Heart Failure · 2024
- Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent EthylJournal of the American College of Cardiology · 2024
- Twenty Year Trends and Sex Differences in Young Adults Hospitalized with Acute Myocardial Infarction: The ARIC Community Surveillance Study2024
- Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort studyThe Lancet Regional Health - Europe · 2024
- Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis PatientsArthritis & Rheumatology · 2024
- Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED TrialJACC Advances · 2024
- Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudyEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2024
- One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trialEuroIntervention · 2024
- Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic StenosisJAMA Cardiology · 2024
- Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trialsENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2024
- Automated Diagnostic Reports from Images of Electrocardiograms at the Point-of-Care2024
- The Canadian Cardiovascular Society Classification of acute atherothrombotic myocardial infarction provides a novel staging scheme based on tissue injury severityEuropean Heart Journal · 2024
- A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty AcidsCardiovascular Drugs and Therapy · 2024
- Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort studyThe Lancet Regional Health - Europe · 2024
- Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention PopulationsJAMA Cardiology · 2024
- Time to Anticoagulation Reversal and Outcomes After Intracerebral HemorrhageJAMA Neurology · 2024
- Trends in Stroke Thrombolysis Care Metrics and Outcomes by Race and Ethnicity, 2003-2021JAMA Network Open · 2024
- Impact of the 2021 European Society for Cardiology prevention guideline’s stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular diseaseEuropean Journal of Preventive Cardiology · 2024
- European Association of Cardio-Thoracic Surgery (EACTS) expert consensus statement on perioperative myocardial infarction after cardiac surgeryEuropean Journal of Cardio-Thoracic Surgery · 2024
- Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trialNature Medicine · 2024
- Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKDClinical Journal of the American Society of Nephrology · 2024
- Enhancing Atrial Fibrillation Prediction Using Multimodal Neural Networks and XGBoost Integration2024
- Exposome in ischaemic heart disease: beyond traditional risk factorsEuropean Heart Journal · 2024
- Omega-3 fatty acids for cardiovascular event loweringEuropean Journal of Preventive Cardiology · 2024
- CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trialPulmonary Circulation · 2024
- Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample StudySunhwan'gi · 2024
- Cost‐Effectiveness of Icosapent Ethyl in REDUCE‐IT USA: Results From Patients Randomized in the United StatesJournal of the American Heart Association · 2023
- The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US PerspectiveAmerican Journal of Cardiovascular Drugs · 2023
- Aldosterone and aldosterone synthase inhibitors in cardiorenal diseaseAJP Heart and Circulatory Physiology · 2023
- Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61European Journal of Heart Failure · 2023
- Effective Medications can Work Only in Patients Who Take Them: Implications for Post-Acute Heart Failure CareEuropean Journal of Heart Failure · 2023
- Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarctionEuropean Heart Journal Open · 2023
- Epeleuton, a novel synthetic ω-3 fatty acid, reduces the hypoxia/reperfusion stress in a mouse model of sickle cell diseaseHaematologica · 2023
- Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trialNature Medicine · 2023
- Serial troponin-I and long-term outcomes in subjects with suspected acute coronary syndromeEuropean Journal of Preventive Cardiology · 2023
- Do patients benefit from omega-3 fatty acids?Cardiovascular Research · 2023
- An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trialsnpj Digital Medicine · 2023
- Antithrombotic and Statin Prescription After Intracerebral Hemorrhage in the Get With The Guidelines-Stroke RegistryStroke · 2023
- The NCDR’s Chest Pain Myocardial Infarction RegistryJACC Advances · 2023
- Abstract 12855: Early vs. Late Transcatheter Aortic Valve Replacement in Acute Heart Failure Hospitalizations: National Inpatient Sample (2015-2020)Circulation · 2023